In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.
The study, led by TSRI Associate Professor Susana Valente, was published online Oct. 17 before print in the journal Cell Reports.
“No other anti-retroviral used in the clinic today is able to completely suppress viral production in infected cells in vivo,” Valente said. “When combining this drug with the standard cocktail of anti-retrovirals used to suppress infection in humanized mouse models of HIV-1 infection, our study found a drastic reduction in virus RNA present—it is really the proof-of-concept for a ‘functional cure.’”
Valente, a pioneer in this new approach, calls it “Block-and-Lock”—the approach blocks reactivation of the virus in cells, even during treatment interruptions, and locks HIV into durable state of latency.
Valente and her colleagues use a derivative of a natural compound called didehydro-Cortistatin A (dCA), which blocks replication in HIV-infected cells by inhibiting the viral transcriptional activator, called Tat, halting viral production, reactivation and replenishment of the latent viral reservoir.
“Combining dCA with anti-retroviral therapy accelerates HIV-1 suppression and prevents viral rebound after treatment interruption, even during strong cellular activation,” Valente said. “It’s important to note that our study uses the maximum tolerable dose of the drug—with virtually no side effects.”
The scientists studied the combination therapy in a mouse model of HIV latency and persistence. Once the combined treatment regimen was halted, viral rebound was delayed up to 19 days, compared with just seven days in mouse models receiving only anti-retroviral treatment.
“This demonstrates the potential of ‘block-and-lock’ strategies,” said TSRI Research Associate Cari F. Kessing, co-first author of the study. “This study shows that a ‘functional cure’ approach can succeed in reducing residual virus in the blood during anti-retroviral treatment and limiting viral rebound during treatment interruption.”
“In half of the dCA treated mice, the virus was undetectable for 16 days after all treatment was halted,” said the University of North Carolina’s Christopher Nixon, another first author.
“We blocked Tat, and the cell’s machinery did the rest,” said TSRI Research Associate Chuan Li, a coauthor of the study. “The result was that the HIV promoter becomes repressed.”
Valente pointed out that the animal models were exposed to just a single month of treatment. “That’s a relatively short period of time,” she said. “We think longer treatments will result in longer, or even permanent, rebound delays. The question is how long? We’re studying that now.”
Because any viral rebound of HIV comes with a host of adverse effects, Valente noted, blocking that rebound would automatically reduce those effects.
“This is the only class of drugs that stops infected cells from making viruses outright,” said Valente. “All current antivirals work later in the viral lifecycle, so only a HIV transcriptional inhibitor like dCA can stop the side effects of low-level virus production.”
The Latest on: HIV
- 23 HIV-infected died in Kailali in a year on February 18, 2019 at 8:30 pm
Twenty-three HIV infected people died in Kailali district in 2018, according to the record of the Seti Zonal Hospital. Lokraj Paneru, chief of the Antiretroviral Therapy (ART) Centre in the zonal ... […]
- Sandy Springs lawmaker aims to make best HIV meds more accessible on February 18, 2019 at 8:28 pm
A local legislator is co-sponsoring a bill that would allow HIV-positive patients on Medicaid to get the most effective medications and could be voted on by the Georgia House of Representatives soon. ... […]
- HIV rates hold steady among transwomen in S.F. on February 18, 2019 at 12:54 pm
Programs in San Francisco to prevent HIV among transgender women are helping to lower the rate of new infections, research finds. However, this vulnerable population—especially people of color or thos... […]
- Federal judge halts discharges of HIV-positive Air Force members on February 18, 2019 at 12:47 pm
A federal judge has ordered the U.S. Department of Defense and Acting Secretary of Defense Patrick Shanahan to halt discharge proceedings against HIV-positive Air Force members who sued in order to ke... […]
- Young, Gay, Latinos Left Behind In The Battle Against HIV In the Bronx on February 18, 2019 at 9:16 am
Despite Donald Trump saying that he intends to end HIV transmissions in the United States by 2030 , The Guardian looks at the ways communities can be overlooked. Communities like the young, gay, Latin... […]
- NYC advocates call for feds to "break the patent" on PrEP, a lifesaving HIV drug on February 18, 2019 at 2:50 am
As the number of people in New York City living with HIV or AIDS continues to rise, local advocates are calling for the federal government to take steps to make the life-saving prevention drug PrEP mo... […]
- Filipinos living with HIV continue to look for love on February 17, 2019 at 9:33 pm
It was her second Valentine’s Day with the man who did not bother to check her past before asking for her hand in marriage. Beatriz (not her real name) met her future husband during a candlelight memo... […]
- HIV informational event scheduled for Tuesday on February 17, 2019 at 9:10 pm
HUNTINGTON — Scheduled for Tuesday, Feb. 19, the Cabell-Huntington Health Department is hosting an informational event about HIV and the facts starting at 5:30 p.m. in the 2nd floor conference room of ... […]
- An important moment in the HIV epidemic: Lindsay Marcus (Opinion) on February 17, 2019 at 2:30 pm
Guest columnist Lindsay Marcus is the program coordinator for the AIDS Funding Collaborative. She’s responsible for the AFC’s discretionary grant making and community initiatives. She serves on the Bo... […]
- Halting HIV by 2030 is a challenge. Here’s why it’s especially tough in the South on February 17, 2019 at 11:00 am
Downstairs, Ted Krug, a volunteer with the Georgia AIDS and STI Information Line, picked up the telephone and tried to calm a 54-year-old woman who was panicking because she’d had unprotected sex with ... […]
via Google News and Bing News